Evidence map›Paper›PMID 31645119›Full record

ArticleJournal of diabetes science and technology2019

Hypoglycemia Prevention via Personalized Glucose-Insulin Models Identified in Free-Living Conditions.

Chiara Toffanin, Eleonora Maria Aiello, Claudio Cobelli, Lalo Magni

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chiara ToffaninDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Italy.ORCID 0000-0003-1288-3456
Eleonora Maria AielloDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Italy.ORCID 0000-0001-5129-8829
Claudio CobelliDepartment of Information Engineering, University of Padova, Italy.ORCID 0000-0002-0169-6682
Lalo MagniDepartment of Civil Engineering and Architecture, University of Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this research is to show the effectiveness of individualized hypoglycemia predictive alerts (IHPAs) based on patient-tailored glucose-insulin models (PTMs) for different subjects. Interpatient variability calls for PTMs that have been identified from data collected in free-living conditions during a one-month trial.

methodsA new impulse-response (IR) identification technique has been applied to free-living data in order to identify PTMs that are able to predict the future glucose trends and prevent hypoglycemia events. Impulse response has been applied to seven patients with type 1 diabetes (T1D) of the University of Amsterdam Medical Centre. Individualized hypoglycemia predictive alert has been designed for each patient thanks to the good prediction capabilities of PTMs.

resultsThe PTMs performance is evaluated in terms of index of fitting (FIT), coefficient of determination, and Pearson's correlation coefficient with a population FIT of 63.74%. The IHPAs are evaluated on seven patients with T1D with the aim of predicting in advance (between 45 and 10 minutes) the unavoidable hypoglycemia events; these systems show better performance in terms of sensitivity, precision, and accuracy with respect to previously published results.

conclusionThe proposed work shows the successful results obtained applying the IR to an entire set of patients, participants of a one-month trial. Individualized hypoglycemia predictive alerts are evaluated in terms of hypoglycemia prevention: the use of a PTM allows to detect 84.67% of the hypoglycemia events occurred during a one-month trial on average with less than 0.4% of false alarms. The promising prediction capabilities of PTMs can be a key ingredient for new generations of individualized model predictive control for artificial pancreas.

Indexed as

Models, BiologicalPancreas, ArtificialAlgorithmsBlood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1HumansHypoglycemiaHypoglycemic AgentsInsulinBlood GlucoseHypoglycemic AgentsInsulinartificial pancreashypoglycemia preventionmodel identificationsafety system

Identifiers

PMID31645119
PMCPMC6835187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.